WallStreetZenWallStreetZen

NASDAQ: RCEL
Avita Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RCEL

Based on 2 analysts offering 12 month price targets for Avita Medical Inc

Min Forecast
$3.50-29.44%
Avg Forecast
$6.75+36.09%
Max Forecast
$10.00+101.61%

Should I buy or sell RCEL stock?

Based on 2 analysts offering ratings for Avita Medical Inc.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RCEL's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates RCEL as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their RCEL stock forecasts and price targets.

RCEL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-17
lockedlocked$00.00+00.00%2026-01-16

1 of 1

Forecast return on equity

Is RCEL forecast to generate an efficient return?

Company
-518.79%
Industry
30%
Market
176.5%
RCEL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RCEL forecast to generate an efficient return on assets?

Company
153.18%
Industry
15.07%
RCEL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RCEL earnings per share forecast

What is RCEL's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.79
Avg 2 year Forecast
-$0.69
Avg 3 year Forecast
$1.17

RCEL revenue forecast

What is RCEL's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$87.1M+21.69%
Avg 2 year Forecast
$130.4M+82.03%
Avg 3 year Forecast
$232.6M+224.77%
RCEL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RCEL revenue growth forecast

How is RCEL forecast to perform vs Medical Devices companies and vs the US market?

Company
44.42%
Industry
9.01%
Market
13.47%
RCEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RCEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RCEL vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
RCEL$4.96$6.75+36.09%Buy
LNSR$12.19N/AN/A
QIPT$3.64$3.65+0.27%Hold
INGN$6.31N/AN/A
NNOX$2.65$5.00+88.68%Strong Buy
View Top Medical Device Stocks

Avita Medical Stock Forecast FAQ

Is Avita Medical Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: RCEL) stock is to Buy RCEL stock.

Out of 2 analysts, 1 (50%) are recommending RCEL as a Strong Buy, 0 (0%) are recommending RCEL as a Buy, 1 (50%) are recommending RCEL as a Hold, 0 (0%) are recommending RCEL as a Sell, and 0 (0%) are recommending RCEL as a Strong Sell.

If you're new to stock investing, here's how to buy Avita Medical stock.

What is RCEL's earnings growth forecast for 2026-2028?

(NASDAQ: RCEL) Avita Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.83%.

Avita Medical's earnings in 2026 is -$48,587,000.On average, 8 Wall Street analysts forecast RCEL's earnings for 2026 to be -$24,110,285, with the lowest RCEL earnings forecast at -$37,824,139, and the highest RCEL earnings forecast at -$5,789,409. On average, 8 Wall Street analysts forecast RCEL's earnings for 2027 to be -$20,995,032, with the lowest RCEL earnings forecast at -$38,124,331, and the highest RCEL earnings forecast at -$643,268.

In 2028, RCEL is forecast to generate $35,774,872 in earnings, with the lowest earnings forecast at $2,701,724 and the highest earnings forecast at $70,759,444.

What is RCEL's revenue growth forecast for 2026-2028?

(NASDAQ: RCEL) Avita Medical's forecast annual revenue growth rate of 44.42% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.01%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.47%.

Avita Medical's revenue in 2026 is $71,610,000.On average, 8 Wall Street analysts forecast RCEL's revenue for 2026 to be $2,669,315,793, with the lowest RCEL revenue forecast at $2,401,532,650, and the highest RCEL revenue forecast at $3,226,140,544. On average, 8 Wall Street analysts forecast RCEL's revenue for 2027 to be $3,992,854,348, with the lowest RCEL revenue forecast at $2,710,729,978, and the highest RCEL revenue forecast at $8,075,153,534.

In 2028, RCEL is forecast to generate $7,124,036,331 in revenue, with the lowest revenue forecast at $3,896,364,197 and the highest revenue forecast at $10,492,002,081.

What is RCEL's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: RCEL) forecast ROA is 153.18%, which is higher than the forecast US Medical Devices industry average of 15.07%.

What is RCEL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year RCEL price target, the average RCEL price target is $6.75, with the highest RCEL stock price forecast at $10.00 and the lowest RCEL stock price forecast at $3.50.

On average, Wall Street analysts predict that Avita Medical's share price could reach $6.75 by Feb 17, 2027. The average Avita Medical stock price prediction forecasts a potential upside of 36.09% from the current RCEL share price of $4.96.

What is RCEL's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: RCEL) Avita Medical's current Earnings Per Share (EPS) is -$1.74. On average, analysts forecast that RCEL's EPS will be -$0.79 for 2026, with the lowest EPS forecast at -$1.23, and the highest EPS forecast at -$0.19. On average, analysts forecast that RCEL's EPS will be -$0.69 for 2027, with the lowest EPS forecast at -$1.24, and the highest EPS forecast at -$0.02. In 2028, RCEL's EPS is forecast to hit $1.17 (min: $0.09, max: $2.31).

What is RCEL's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: RCEL) forecast ROE is -518.79%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.